Hello Heart Appoints Bill Otten as Commercial President

Health industry leader brings decades of sales and go-to-market experience to scale Hello Heart’s commercialization strategy and revenue operations

Hello Heart, the digital leader in preventive heart health, today announced the appointment of healthcare industry veteran Bill Otten as Commercial President, reporting into Maayan Cohen, CEO and co-founder. He joins the company following another recent key hire, renowned cardiologist Jayne Morgan, MD who joined as VP, Medical Affairs. Together with Hello Heart’s executive team, they aim to advance the company’s mission of improving heart health for millions nationwide.

Otten joins Hello Heart with a wealth of experience in healthcare technology, having successfully scaled several companies in the space, including Clearwave, where he grew revenue to over $750 million as chief revenue officer. He also led sales at ADP for 14 years across multiple successful market divisions.

“Bill brings the exact skill set and expertise we need to push Hello Heart’s business into its next stage of growth in order to reach its highest potential,” said Maayan Cohen, CEO and co-founder, Hello Heart. “We are incredibly excited to work with Bill in scaling Hello Heart to bring our preventive heart health platform to every American who needs it.”

Dr. Morgan, a cardiologist and healthcare thought leader with over 20 years of clinical experience, joined Hello Heart to help lead its Medical Affairs team. Her dedication to health equity and preventive care has shaped her career, which includes leadership positions at Piedmont Healthcare and major research contributions focused on women’s heart health. “With Dr. Morgan and Bill on board to help lead our growth and clinical strategies, Hello Heart is well-positioned to become the leading heart health solution for health plans and private and public sector employers,” added Cohen.

An estimated 122 million Americans, or nearly half of U.S. adults, have high blood pressure —the top heart attack and stroke risk factor—and employers and health plans need a proven solution to support the health of their members and lower the increasing costs of heart attack and stroke care. Hello Heart's connected heart health monitor and mobile app offer personalized tracking and AI-driven digital coaching, representing a scalable solution for managing heart health risk factors and improving clinical and financial outcomes.

Otten is based in Atlanta and holds an MBA from Johns Hopkins University. Dr. Morgan is also based in Atlanta and received her Doctor of Medicine from Michigan State University College of Human Medicine.

About Hello Heart

Hello Heart is on a mission to change the way people care for their hearts. The company provides the first app and connected heart monitor to help people track and manage their heart health and get real-time tips. With Hello Heart, people can take steps to control their risk of heart attacks and stroke – the leading cause of death in the United States. Peer-reviewed studies have shown that high-risk users of Hello Heart have seen meaningful drops in blood pressure, cholesterol and even weight.

Recognized as the digital leader in preventive heart health, Hello Heart is trusted by more than 130 leading Fortune 500 and government employers, national health plans, and labor organizations such as 3M, Lenovo, Northwestern Mutual, the City of Fort Worth, and the Cleveland Bakers and Teamsters Pension Fund. Hello Heart clients can save $1,676 per enrolled user annually according to an independent analysis by the Validation Institute.

Founded in 2013, Hello Heart has raised more than $138 million from top venture firms including Khosla Ventures, IVP, and Stripes. Hello Heart is a best-in-class solution on the American Heart Association’s Innovators’ Network, CVS Health Point Solutions Management offering, and other leading health solution platforms. Visit www.helloheart.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241029192623/en/